Pharmaceutical Information For You !
Updates from Pharmainfo.net website
Sunday, June 20, 2010
Exelixis, Inc. Regains Full Rights To Develop And Commercialize XL184 From Bristol-Myers Squibb Co.
http://ping.fm/gJO6u
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment